Search the Newsreel

KAP *** BORUSAN BİRLEŞİK BORU FABRİKALARI SANAYİ VE TİCARET A.Ş. *** BRSAN *** Geleceğe Dönük Değerlendirmeler

Sidoti Brokers Decrease Earnings Estimates for USNA

Earnings Report: Sanathan Textiles Limited Missed Revenue Estimates By 9.5%

USANA Health Sciences (USNA) Stock Sinks After Hiya Impairment And Loss Shock

USANA Health Sciences (USNA) experienced a significant stock drop of 34.2% after reporting a Q2 2026 loss per share of US$1.16 on revenue of US$223.3m, compounded by a US$29m non-cash goodwill impairment related to its Hiya brand. The company swung from a profit of …

Sanathan Textiles Q1 Results: Consolidated revenue surges 79% YoY

USANA Health Sciences, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

NULL

Should USANA Health Sciences (USNA) Revisit Its Valuation After Lowered Guidance And Q2 Loss?

USANA Health Sciences (USNA) experienced a significant share price drop and reported a Q2 2026 net loss, lowered full-year guidance, and a $29 million goodwill impairment. Despite these setbacks, Simply Wall St's analysis suggests the stock is undervalued with a Price-to-Sales ratio of 0.3x …

LOGO YAZILIM - KAP Haberleri - 2026-08-05 tarihli

Earnings call transcript: USANA Health Sciences posts Q2 2026 loss, stock sinks 28%

USANA Health Sciences (USNA) reported a significant Q2 2026 loss of 7 cents per share on $223 million revenue, widely missing analyst expectations, leading to a 28% stock decline. The loss was attributed to a non-cash goodwill impairment for its Hiya unit, a packaging …

Asana, Snowflake, Atlassian, Guidewire Software, and Adobe Stocks Trade Up, What You Need To Know

Asana, Snowflake, Atlassian, Guidewire Software, and Adobe Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the afternoon session after the software sector caught a massive tailwind, fueled by easing geopolitical tensions and a fresh wave of …

Why USANA (USNA) Stock Is Nosediving

Shares of USANA Health Sciences (USNA) dropped significantly after the company reported second-quarter 2026 results that missed Wall Street's revenue and earnings expectations, posting an adjusted loss per share against forecasts for a profit. This steep decline overshadowed the reaffirmation of its full-year revenue …

USANA Reports Q2 2026 Financial Results

USANA Health Sciences, Inc. announced its Q2 2026 financial results, with net sales of $223 million and a net loss of $21.4 million. The company experienced mixed performance, with its Core Nutritional business meeting expectations but its ventures, Hiya and Rise Wellness, performing below …

Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday

Reeder Teknoloji Sanayi ve Ticaret A.S. İşlem Fikirleri — BIST:REEDR

USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August

Kevin Guest, Chairman and CEO of USANA Health Sciences, offers five practical tips to cultivate happiness during August's Happiness Happens Month. These tips include noticing existing good, creating moments of joy, recognizing others, helping without being asked, and protecting time for important people and …

USANA CEO's Parents Bought a Piano Before a Car—They Still Own It

USANA Health Sciences CEO Kevin Guest shares five happiness tips for both work and home to celebrate Happiness Happens Month in August. He emphasizes intentionally noticing good things, creating joyful moments, recognizing others, helping without being asked, and protecting time for important relationships. Guest …

Lazard Asset Management LLC Invests $1.26 Million in USANA Health Sciences, Inc. $USNA

Lazard Asset Management LLC has acquired a new stake of 72,395 shares in USANA Health Sciences, Inc. (NYSE:USNA) worth approximately $1.26 million. This investment gives Lazard Asset Management a 0.39% stake in the company, where institutional investors and hedge funds collectively own 54.25%. USANA …

USANA Updates 2026 Sales Outlook After Hiya, Rise Fall Short

USANA Health Sciences reported a Q2 2026 net loss of $(21.4) million, including a $29.1 million impairment charge, and updated its fiscal year 2026 sales outlook downward due to underperformance in its Hiya and Rise Wellness ventures. The company's core nutritional business performed as …

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade) (NYSE:USNA)

Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Sanara MedTech Inc. (SMTI) on behalf of investors. This investigation follows a 24.7% stock price drop on November 12, 2026, after Sanara announced the discontinuation of its Tissue Health Plus program, incurring a $26.5 …

USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates

USANA Health Sciences (USNA) reported a Q2 loss of $0.07 per share, missing the Zacks Consensus Estimate of $0.43, and revenues of $223.27 million, falling short of the $235.85 million reported a year ago. Despite outperforming the market year-to-date with a 16.4% stock gain, …

USANA Health Sciences (NYSE:USNA) Posts Earnings Results, Misses Estimates By $0.50 EPS

USANA Health Sciences (NYSE:USNA) reported quarterly earnings, missing analyst estimates with a loss of $0.07 per share against a projected $0.43 profit, and revenue of $223.27 million, below the $235 million estimate. Shares traded up $0.05 to $22.89, giving the company a market capitalization …

USANA Health Sciences (NYSE: USNA) swings to Q2 loss, trims 2026 forecast

USANA Health Sciences reported a Q2 2026 net loss of $(21.4) million, a significant swing from a net gain of $9.7 million in the prior year, primarily due to a $29.1 million goodwill impairment charge related to its Hiya reporting unit. The company also …

Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital

Freedom Capital downgraded Sanara MedTech (NASDAQ:SMTI) from "strong buy" to "hold," aligning with several other recent rating cuts for the company. The current analyst consensus is "Reduce," with a $35.00 price target, and SMTI is trading near its 52-week high at $34.00. Institutional investors, …

Sanathan Textiles Q2 Results: Earnings call audio released

Earnings call transcript: Sanathan Textiles posts strong Q1 2026 growth

Sana Biotechnology (SANA) Projected to Release Earnings on Monday

Sana Biotechnology (SANA) is expected to report its Q2 2026 earnings on Monday, August 10th, with analysts projecting a loss of $0.1469 per share. The company's shares opened at $3.08, and its market capitalization is approximately $858 million. Analyst sentiment is mixed but leans …

SANATHAN: Robust revenue and EBITDA growth achieved amid volatile input costs and capacity ramp-up

Sanathan Textiles Q1 results FY27: PAT Rs 23 Cr, Revenue Rs 1,334

USANA (NYSE:USNA) Misses Q2 CY2026 Sales Expectations, Stock Drops 19.2%

USANA Health Sciences (NYSE:USNA) Releases FY 2026 Earnings Guidance

Sanathan Textiles consolidated net profit declines 41.08% in the June 2026 quarter

Sanathan Textiles Q1FY27: Standalone PAT rises 37.5%, Punjab facility scales up

REEDER TEKNOLOJI - KAP Haberleri - 2026-08-03 tarihli

Asana to Announce Second Quarter Fiscal Year 2027 Financial Results on Thursday, September 3, 2026

SAN FRANCISCO, August 03, 2026--(BUSINESS WIRE)--Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), the operating system for human-agent teams, announced today that it will release financial results for the second quarter fiscal year 2027 on Thursday, September 3, after the close of the U.S. markets. In conjunction …

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Sanara MedTech Inc. (SMTI) to MiMedx Group, Inc. (MDXG). KSF is examining whether the offered consideration of $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share undervalues the …